Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 2, 2023. (Total: 223599Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 13 (of 13 Records)

Query Trace: Achievement and FLT3[original query]
Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B.
Haematologica 2009 Jan 94 (1): 54-60.
Schlenk Richard F, Döhner Konstanze, Kneba Michael, Götze Katharina, Hartmann Frank, Del Valle Francesco, Kirchen Heinz, Koller Elisabeth, Fischer Jörg T, Bullinger Lars, Habdank Marianne, Späth Daniela, Groner Silja, Krebs Bernhard, Kayser Sabine, Corbacioglu Andrea, Anhalt Andreas, Benner Axel, Fröhling Stefan, Döhner Hartmut,
NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS).
Blood 2009 May 113 (21): 5250-3.
Schneider Friederike, Hoster Eva, Unterhalt Michael, Schneider Stephanie, Dufour Annika, Benthaus Tobias, Mellert Gudrun, Zellmeier Evelin, Bohlander Stefan K, Feuring-Buske Michaela, Buske Christian, Braess Jan, Fritsch Susanne, Heinecke Achim, Sauerland Maria C, Berdel Wolfgang E, Buechner Thomas, Woermann Bernhard J, Hiddemann Wolfgang, Spiekermann Karst
Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse.
Cancer 2011 (10): 2156-62.
Tiribelli Mario, Geromin Antonella, Michelutti Angela, Cavallin Margherita, Pianta Annalisa, Fabbro Dora, Russo Domenico, Damante Giuseppe, Fanin Renato, Damiani Danie
The prognostic value of CXCR4 in acute myeloid leukemia.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2013 Jan 21 (1): 79-84.
Ahn Jeong Yeal, Seo Katie, Weinberg Olga K, Arber Daniel
Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG).
Blood 2013 Jan 121 (1): 170-7.
Paschka Peter, Du Juan, Schlenk Richard F, Gaidzik Verena I, Bullinger Lars, Corbacioglu Andrea, Späth Daniela, Kayser Sabine, Schlegelberger Brigitte, Krauter Jürgen, Ganser Arnold, Köhne Claus-Henning, Held Gerhard, von Lilienfeld-Toal Marie, Kirchen Heinz, Rummel Mathias, Götze Katharina, Horst Heinz-August, Ringhoffer Mark, Lübbert Michael, Wattad Mohammed, Salih Helmut R, Kündgen Andrea, Döhner Hartmut, Döhner Konstan
Sorafenib Maintenance Appears Safe and Improves Clinical Outcomes in FLT3-ITD Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation.
Clinical lymphoma, myeloma & leukemia 2015 May 15 (5): 298-302.
Antar Ahmad, Kharfan-Dabaja Mohamed A, Mahfouz Rami, Bazarbachi A
High EVI1 Expression Predicts Poor Outcomes in Adult Acute Myeloid Leukemia Patients with Intermediate Cytogenetic Risk Receiving Chemotherapy.
Medical science monitor : international medical journal of experimental and clinical research 2018 2 24 758-767.
Qin Ya-Zhen, Zhao Ting, Zhu Hong-Hu, Wang Jing, Jia Jin-Song, Lai Yue-Yun, Zhao Xiao-Su, Shi Hong-Xia, Liu Yan-Rong, Jiang Hao, Huang Xiao-Jun, Jiang Qi
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG).
Cancers 2020 8 12 (8): .
Salmoiraghi Silvia, Cavagna Roberta, Zanghì Pamela, Pavoni Chiara, Michelato Anna, Buklijas Ksenija, Elidi Lara, Intermesoli Tamara, Lussana Federico, Oldani Elena, Caprioli Chiara, Stefanoni Paola, Gianfaldoni Giacomo, Audisio Ernesta, Terruzzi Elisabetta, De Paoli Lorella, Borlenghi Erika, Cavattoni Irene, Mattei Daniele, Scattolin Annamaria, Tajana Monica, Ciceri Fabio, Todisco Elisabetta, Campiotti Leonardo, Corradini Paolo, Fracchiolla Nicola, Bassan Renato, Rambaldi Alessandro, Spinelli Oriet
Allogeneic hematopoietic stem cell transplantation at the first remission for younger adults with FLT3-internal tandem duplication AML: The JALSG AML209-FLT3-SCT study.
Cancer science 2020 5 111 (7): 2472-2481.
Kawashima Naomi, Ishikawa Yuichi, Atsuta Yoshiko, Sawa Masashi, Ozawa Yukiyasu, Hayashi Masaki, Kohno Akio, Tomita Akihiro, Maeda Tomoya, Sakaida Emiko, Usuki Kensuke, Hagihara Maki, Kanamori Heiwa, Matsuoka Hiroshi, Kobayashi Miki, Asou Norio, Ohtake Shigeki, Matsumura Itaru, Miyazaki Yasushi, Naoe Tomoki, Kiyoi Hitoshi,
[Detection of activating mutations in RAS/RAF/MEK/ERK and JAK/STAT signaling pathways].
Terapevticheskii arkhiv 2020 12 92 (7): 31-42.
Zarubina K I, Parovichnikova E N, Surin V L, Pshenichnikova O S, Gavrilina O A, Isinova G A, Troitskaia V V, Sokolov A N, Gal'tseva I V, Kapranov N M, Davydova I O, Obukhova T N, Sudarikov A B, Savchenko V
The impact of FLT3 mutation clearance and treatment response after gilteritinib therapy on overall survival in patients with FLT3 mutation-positive relapsed/refractory acute myeloid leukemia.
Cancer medicine 2020 12 10 (3): 797-805.
Altman Jessica K, Perl Alexander E, Hill Jason E, Rosales Matt, Bahceci Erkut, Levis Mark
Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis.
Annals of hematology 2022 Jun .
Shimony Shai, Canaani Jonathan, Kugler Eitan, Nachmias Boaz, Ram Ron, Henig Israel, Frisch Avraham, Ganzel Chezi, Vainstein Vladimir, Moshe Yakir, Aumann Shlomzion, Yeshurun Moshe, Ofran Yishai, Raanani Pia, Wolach Of
High WT1 expression predicted induction chemotherapy failure in acute myeloid leukemia patients with non-favorable cytogenetic risk.
Clinical and experimental medicine 2023 1 .
Xu Nan, Chen Wen-Min, Li Ling-Di, Long Ling-Yu, Wang Xu, Jiang Qian, Jiang Hao, Huang Xiao-Jun, Qin Ya-Zh
TOP